Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredients Bismuth Subcitrate, Tetracycline And Metronidazole (A02Bd08) As Part Of A So-Called Open House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 81987976

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient bismuth subcitrate, tetracycline and metronidazole (A02BD08) within the period from July 1st, 2024 to June 30th, 2026 with the possibility of concluding the contract at any time (open -house model). In the open house procedure, medicines according to the BfArM list according to Section 35 Para. 5a SGB V (children's medicines) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Bismutsubcitrat, Tetracyclin und Metronidazol

Gt Ref Id - 81987976

Deadline - Apr 30, 2026